267 related articles for article (PubMed ID: 21094904)
1. Epac2-dependent rap1 activation and the control of islet insulin secretion by glucagon-like peptide-1.
Leech CA; Chepurny OG; Holz GG
Vitam Horm; 2010; 84():279-302. PubMed ID: 21094904
[TBL] [Abstract][Full Text] [Related]
2. Phospholipase C-ε links Epac2 activation to the potentiation of glucose-stimulated insulin secretion from mouse islets of Langerhans.
Dzhura I; Chepurny OG; Leech CA; Roe MW; Dzhura E; Xu X; Lu Y; Schwede F; Genieser HG; Smrcka AV; Holz GG
Islets; 2011; 3(3):121-8. PubMed ID: 21478675
[TBL] [Abstract][Full Text] [Related]
3. Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic β cells.
Zhang M; Robitaille M; Showalter AD; Huang X; Liu Y; Bhattacharjee A; Willard FS; Han J; Froese S; Wei L; Gaisano HY; Angers S; Sloop KW; Dai FF; Wheeler MB
Mol Cell Proteomics; 2014 Nov; 13(11):3049-62. PubMed ID: 25044020
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 enhances glucokinase activity in pancreatic β-cells through the association of Epac2 with Rim2 and Rab3A.
Park JH; Kim SJ; Park SH; Son DG; Bae JH; Kim HK; Han J; Song DK
Endocrinology; 2012 Feb; 153(2):574-82. PubMed ID: 22147008
[TBL] [Abstract][Full Text] [Related]
5. Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell.
Holz GG
Diabetes; 2004 Jan; 53(1):5-13. PubMed ID: 14693691
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide 1 potentiates glucotoxicity-diminished insulin secretion via stimulation of cAMP-PKA signaling in INS-1E cells and mouse islets.
Luo G; Kong X; Lu L; Xu X; Wang H; Ma X
Int J Biochem Cell Biol; 2013 Feb; 45(2):483-90. PubMed ID: 23220045
[TBL] [Abstract][Full Text] [Related]
7. Intra-islet glucagon confers β-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon.
Cabrera O; Ficorilli J; Shaw J; Echeverri F; Schwede F; Chepurny OG; Leech CA; Holz GG
J Biol Chem; 2022 Feb; 298(2):101484. PubMed ID: 34896391
[TBL] [Abstract][Full Text] [Related]
8. Epac2-dependent mobilization of intracellular Ca²+ by glucagon-like peptide-1 receptor agonist exendin-4 is disrupted in β-cells of phospholipase C-ε knockout mice.
Dzhura I; Chepurny OG; Kelley GG; Leech CA; Roe MW; Dzhura E; Afshari P; Malik S; Rindler MJ; Xu X; Lu Y; Smrcka AV; Holz GG
J Physiol; 2010 Dec; 588(Pt 24):4871-89. PubMed ID: 21041529
[TBL] [Abstract][Full Text] [Related]
9. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure.
Kim M; Platt MJ; Shibasaki T; Quaggin SE; Backx PH; Seino S; Simpson JA; Drucker DJ
Nat Med; 2013 May; 19(5):567-75. PubMed ID: 23542788
[TBL] [Abstract][Full Text] [Related]
10. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
Lee YS; Jun HS
Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
[TBL] [Abstract][Full Text] [Related]
11. Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose.
Zhang Y; Han C; Zhu W; Yang G; Peng X; Mehta S; Zhang J; Chen L; Liu Y
Cells; 2021 Sep; 10(9):. PubMed ID: 34572144
[TBL] [Abstract][Full Text] [Related]
12. New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.
Holz GG
Horm Metab Res; 2004; 36(11-12):787-94. PubMed ID: 15655710
[TBL] [Abstract][Full Text] [Related]
13. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
[TBL] [Abstract][Full Text] [Related]
14. Expression of cAMP-regulated guanine nucleotide exchange factors in pancreatic beta-cells.
Leech CA; Holz GG; Chepurny O; Habener JF
Biochem Biophys Res Commun; 2000 Nov; 278(1):44-7. PubMed ID: 11071853
[TBL] [Abstract][Full Text] [Related]
15. Absence of the glucagon-like peptide-1 receptor does not affect the metabolic phenotype of mice with liver-specific G(s)α deficiency.
Chen M; Mema E; Kelleher J; Nemechek N; Berger A; Wang J; Xie T; Gavrilova O; Drucker DJ; Weinstein LS
Endocrinology; 2011 Sep; 152(9):3343-50. PubMed ID: 21771891
[TBL] [Abstract][Full Text] [Related]
16. Rap1 promotes multiple pancreatic islet cell functions and signals through mammalian target of rapamycin complex 1 to enhance proliferation.
Kelly P; Bailey CL; Fueger PT; Newgard CB; Casey PJ; Kimple ME
J Biol Chem; 2010 May; 285(21):15777-85. PubMed ID: 20339002
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl Peptidase 4 Inhibition Alleviates Shortage of Circulating Glucagon-Like Peptide-1 in Heart Failure and Mitigates Myocardial Remodeling and Apoptosis via the Exchange Protein Directly Activated by Cyclic AMP 1/Ras-Related Protein 1 Axis.
Aoyama M; Kawase H; Bando YK; Monji A; Murohara T
Circ Heart Fail; 2016 Jan; 9(1):e002081. PubMed ID: 26721911
[TBL] [Abstract][Full Text] [Related]
18. Restoration of Glucose-Stimulated Cdc42-Pak1 Activation and Insulin Secretion by a Selective Epac Activator in Type 2 Diabetic Human Islets.
Veluthakal R; Chepurny OG; Leech CA; Schwede F; Holz GG; Thurmond DC
Diabetes; 2018 Oct; 67(10):1999-2011. PubMed ID: 29986926
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells.
Ma X; Guan Y; Hua X
J Diabetes; 2014 Sep; 6(5):394-402. PubMed ID: 24725840
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.
Gromada J; Brock B; Schmitz O; Rorsman P
Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):252-62. PubMed ID: 15569269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
